trending Market Intelligence /marketintelligence/en/news-insights/trending/lqJDSSOrjOZYZJjm9ZbDMA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Synthorx names chairman

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Synthorx names chairman

Synthorx Inc. named board member Pratik Shah as the company's chairman.

The company also appointed Andrew Powell to the board.

Powell serves as a director on the boards of Landec Corp. and Aclaris Therapeutics Inc. In addition, he acted as senior vice president, general counsel and corporate secretary of CollaGenex Pharmaceuticals, Inc., Cornerstone Therapeutics, ImClone Systems LLC, InterMune, Inc. and Medivation, Inc. He was also vice president, chief international counsel at Baxter International Inc.

La Jolla, Calif.-based Synthorx is a biotechnology company that discovers and develops protein therapeutics.